PHV-wordings
Nomegestrol or Chlormadinone
Referral
|
10/11/2022
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Dexlansoprazole, Lansoprazole
PSUR-outcome
|
10/11/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Dexketoprofen / Tramadol
PSUR-outcome
|
28/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Bupropion
PSUR-outcome
|
28/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Botulinumtoxin Typ A
PSUR-outcome
|
28/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Valaciclovir
PSUR-outcome
|
28/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Terbutaline
PSUR-outcome
|
28/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Codeine/Ibuprofen
PRAC signal recommendation
|
25/10/2022
Risk for renal tubular acidosis and hypokalaemia. Further information and the changes to the product information in all EU languages are available on the EMA website.
Ciclosporin (systemic use)
PSUR-outcome
|
20/10/2022
Further information and amendments to the product information in all EU languages are available on the EMA website.
Ethinylestradiol
Additional template
|
18/10/2022
Further information is available in the CMDh press release (Report from the meeting held on 19-20 July 2022) on the HMA-Website.
